HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1

BACKGROUND: The efficacy of licensed direct-acting antiviral (DAA) regimens is assumed to be the same for hepatitis C virus (HCV)–monoinfected patients (HCV-Mono) and HIV/HCV-coinfected patients (HCV-Co). However, the high sustained viral response (SVR) rates of DAA regimens and the small number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Berenguer, Juan, Calleja, José Luis, Montes, María Luisa, Gil, Ángela, Moreno, Ana, Bañares, Rafael, Aldámiz-Echevarría, Teresa, Albillos, Agustín, Téllez, María Jesús, Olveira, Antonio, Domínguez, Lourdes, Fernández, Inmaculada, García-Samaniego, Javier, Polo, Benjamín A, Álvarez, Beatriz, Ryan, Pablo, Barrio, José, Devesa, María J, Benítez, Laura, Santos, Ignacio, Buey, Luisa García, Sanz, José, Poves, Elvira, Losa, Juan E, Fernández-Rodríguez, Conrado, Jarrín, Inmaculada, Calvo, María J, González-García, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534283/
https://www.ncbi.nlm.nih.gov/pubmed/31139679
http://dx.doi.org/10.1093/ofid/ofz214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534283/
https://www.ncbi.nlm.nih.gov/pubmed/31139679
http://dx.doi.org/10.1093/ofid/ofz214

Ejemplares similares